期刊文献+

Al(OH)3和CpG ODN免疫佐剂对丙型肝炎病毒多表位抗原PCX3疫苗免疫效果的影响 被引量:3

The Immune Evaluation of Vaccine Adjuvants:Al(OH)_3 and CpG ODN on Multiple-Epitope Antigen of Hepatitis C Virus(PCX3)
下载PDF
导出
摘要 以HCV蛋白疫苗PCX3为抗原,分别加入Al(OH)3佐剂,CpG ODN佐剂,以及两种佐剂联合作用的复合佐剂,对雄性六周龄BALB/c小鼠进行常规免疫.与其他免疫组相比,Al(OH)3和CpG ODN复合佐剂与PCX3抗原联合作用组产生的特异性IgG(1×106)和IgM(1×105)抗体滴度最高、持续时间最长;自然杀伤效应(CTL)实验显示该组小鼠诱发的CTL杀伤效应(40.91%)显著高于其他免疫组(P<0.05);流式细胞仪对小鼠淋巴细胞亚群进行分型分析发现:从第2周开始,该组小鼠体内CD4+/CD8+细胞比值(3.26)显著高于PCX3抗原单独作用组(P<0.05).结果表明,Al(OH)3和CpG ODN复合佐剂可以从体液免疫和细胞免疫两方面对HCV蛋白疫苗PCX3的免疫效果进行增强,并且具有协同效应. The antigen-HCV protein vaccine PCX3 with Al(OH)3 adjuvant,CpG ODN adjuvant,and the combination of them were separately used to immunize six-week-old male BALB/c mice.Compared with other groups,the group which has PCX3 antigen and the combined-adjuvant of Al(OH)3 and CpG ODN,was detected the highest specific IgG(1×106) and IgM(1×105) antibody titer and the longest lasting time by ELISA method;The CTL response(40.91%) significantly higher than other groups(P〈0.05);Since the 2th week,the ratio of CD4+/CD8+ T lymphocyte was significantly higher than the group with PCX3 antigen alone with cyto metry technology(P〈0.05).The results demonstrated that the combined-adjuvant of Al(OH)3 and CpG ODN can enhance the immune effect of HCV protein vaccine PCX3 in both humoral immunity and cellular immunity aspect,and has a synergistic effect.
出处 《复旦学报(自然科学版)》 CAS CSCD 北大核心 2009年第5期661-667,共7页 Journal of Fudan University:Natural Science
基金 国家高技术研究发展计划目标导向课题资助项目(2006AAD2A228)
关键词 HCV HCV蛋白疫苗 AL(OH)3 CPG ODN 体液免疫 细胞免疫 HCV HCV protein vaccine Al(OH)3 CpG ODN humoral immunity cellular immunity
  • 相关文献

参考文献10

  • 1Tellinghuisen T L, Evans M J, Rice C M, et al. Studying hepatitis C virus: making the best of a bad virus [J]. Journal of Virology, 2007,81(17) . 8853-8867.
  • 2Enke J, Putlitz J, Geissler M, et al. Genetic immunization generates cellar and humoral immune responses against the nonstructural proteins of the hepatitis C virus in a murine model [J].The Journal of Immunology,1998,16: 4917.
  • 3Feld J J, Hoofnagle J H. Mechanism of action of interferon and ribavirin in treatment of hepatitis C [J]. Nature, 2005,436 : 967-972.
  • 4王子来,陈丽珊,李琦涵,陈肖楚,程帆,任大明.HCV多表位抗原基因的表达及其在小鼠中诱导的抗体应答研究[J].复旦学报(自然科学版),2004,43(2):163-168. 被引量:6
  • 5Chen L S, Mercer D F, Huang J S, et al. Immunization with a synthetic multiple-epitope antigen induces humoral and cellular immune response to hepatitis C virus in mice[J]. Viral Immunology, 2007,20(1): 170-179.
  • 6Brewer J M, Alexander J. Cytokines and the mechanisms of action of vaccine adjuvants [J]. Cytokines Cell Mol Ther, 1997,3(2) : 33-46.
  • 7Krieg A M. CpG motifs in bacterial DNA and their immune effects [J]. AnnualRev Immunol, 2002,20: 709-4760.
  • 8Davis H L, Weeratna R, Waldschmidt T J, et al. CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans[J]. Vaccine, 2000,18(18) : 1920-1924.
  • 9Davis H L, Weeratna R, Waldschmidt T J, etal. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen [J]. J Immunol, 1998,160(2): 870-876.
  • 10Weeratna R D, Brazolo-Millatl C L, Mccluskie M J, et al. Priming of immune response to hepatitis B surface antigen in young mice immunized in the prescence of maternally derived antibodies [J]. FEMS Immunol Med Microbiol, 2001,30(3) :241- 247.

二级参考文献19

  • 1Hunziker I P,Zurbriggen R,Glueck R,et al.Perspectives:Towards a peptide-based vaccine against hepatitis C virus [J].Mol Immunol,2001,8(6):475-484.
  • 2Nemchinov L G,Liang T J,Rifaat M M,et al.Development of a plant-derived subunit vaccine candidate against hepatitis C virus [J].Arch Virol,2000,145(12):2557-2573.
  • 3Esumi M,Rikihisa T,Nishimura S,et al.Experimental vaccine activities of recombinant E1 and E2 glycoproteins and hypervariable region 1 peptides of hepatitis C virus in chimpanzees [J].Arch Virol,1999,144(5):973-980.
  • 4Kapadia S B,Brideau-Andersen A,Chisari F V.Interference of hepatitis C virus RNA replication by short interfering RNAs [J].Proc Natl Acad Sci USA,2003,100(4):2014-2018.
  • 5Randall G,Grakoui A,Rice C M.Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs [J].Proc Natl Acad Sci U S A,2003,100(1):235-240.
  • 6Choo Q L,Kuo G,Ralston R,et al.Vaccination of chimpanzees against infection by the hepatitis C virus [J].Proc Natl Acad Sci USA,1994,91(4):1294.
  • 7Sallberg M,Ruden U,Wahren B,et al.Immune response to a single peptide containing an immunodominant region of hepatitis C virus core protein:The isotypes and the recognition site [J].Immunol Lett,1992,33(1):300.
  • 8Jolivet-Reynaud C,Dalbon P,Viola F,et al.HCV core immunodominant region analysis using mouse monoclonal antibodies and human sera:Characterization of major epitopes useful for antigen detection [J].J Med Virol,1998,56(4):300.
  • 9Goeser T,Muller H M,Ye J,et al.Characterazation of antigenic determinants in the core antigen of the hepatitis C virus [J].Virology,1994,205(2):462.
  • 10Kakimi K,Kuribayashi K,Iwashiro M,et al.Hepatitis C virus core region:Helper T cell epitopes recognized by BALB/c and C57BL/6 mice [J].J Gen Virol,1995,76(5):1205.

共引文献5

同被引文献43

  • 1赵四喜,樊斌堂.中西药与免疫佐剂对仔猪白痢的影响[J].黑龙江畜牧兽医,1994(4):19-19. 被引量:6
  • 2张继东,王志祥.中草药多糖的免疫调节机制及其应用[J].饲料工业,2006,27(6):1-4. 被引量:15
  • 3程安玮,金征宇,万发春.甘草多糖对小鼠脾淋巴细胞的免疫作用[J].安徽农业科学,2007,35(6):1660-1661. 被引量:16
  • 4Moser C, Jon D, Martin T, et al.A recombinant classi- cal swinefever virus stably expresses marker gene [J].JVirol, 1998,72(6):5318-5322.
  • 5william E P. Fundamental immunology[M]. 4th ed. New York:Lippincott Raven, 1988:1387-1427.
  • 6Cooper P D, McComb C, Steele E J. The adjuwanticity of Algammulin, a new vaccine adjuvant[J].Vaccine, 1991, 9 (6):408-415.
  • 7Dotsika E, Karagouni E, Sundquist B, et al. Influence of quillaja saponaria triterpenoid content on the immunomodulatory capacity of Epstein Barr virus ISCOMs [J]. Scand J Immuno, 1997, 45 (3) :261-265.
  • 8Jun-ling Sun, Yuan-liang Hu, De-yun Wang, et al. Immun- ologic enhancement of compound Chineseherbal medic- inal ingredients and their efficacy comparison with compound Chinese herbal medicines[J].Vaccine, 2006, 24(13):2343-2348.
  • 9Evangelista M, Zigmond S, Boone C. Formins signaling effectors for assembly and polarization of actin filaments[J].J Cell Sci, 2003,116(Pt13):2603-2611.
  • 10Tsuhoi S, Takada H, Hara T, et al. FBP17 mediates a common molecular step in the formation of podosom- es and phagocytic cupsin macrophages[J].J Biol Chem, 2009,284(13):8548-8556.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部